Moving projects along the pipeline

Pfizer has moved a high proportion of its projects from one stage of development to the next in the last two years.
Continue reading

Approach to collaborative R&D

Eisai engages in collaborative R&D that addresses the needs of people in low- and middle-income countries.
Continue reading

Commitment to R&D for AMR

AstraZeneca, GSK, Johnson & Johnson, Merck & Co, Merck KGaA, Novartis, Pfizer, Roche, Sanofi
Nine companies have committed to R&D for antimicrobial resistance (AMR), signing the Davos Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance.
Continue reading